For a symptomatic adult with third-degree atrioventricular block, should I choose a Micra leadless pacemaker or a dual-chamber permanent pacemaker?

Dual-Chamber Pacemaker is Recommended for Third-Degree AV Block

For a symptomatic adult with third-degree atrioventricular block, you should choose a dual-chamber permanent pacemaker over a Micra leadless pacemaker. This is a Class I recommendation with Level of Evidence C from established guidelines 1, 2, 3, 2, 3.

Guideline-Based Rationale

The HRS/ACCF expert consensus and ACC/AHA/HRS guidelines explicitly state that dual-chamber pacing is recommended in patients with AV block 1. This recommendation prioritizes maintaining atrioventricular synchrony, which directly impacts:

• Mortality reduction: Dual-chamber pacing in complete AV block with sinus rhythm reduces all-cause mortality (HR 0.807) and cardiovascular mortality (HR 0.766) compared to single-chamber ventricular pacing 4
• Heart failure prevention: Lower incidence of heart failure (HR 0.908) with dual-chamber systems 4
• Atrial fibrillation prevention: Significantly reduced AF development (HR 0.778) 4
• Stroke reduction: Lower ischemic stroke risk (HR 0.873) 4

When Single-Chamber (Including Micra) May Be Acceptable

Guidelines specify that single-chamber ventricular pacing is an acceptable alternative only in specific clinical situations 1:

• Sedentary patients with limited activity expectations
• Significant medical comorbidities likely to impact survival and clinical outcomes
• Technical issues such as vascular access limitations that preclude or increase risk of atrial lead placement
• Permanent atrial fibrillation where AV synchrony cannot be maintained

The Micra Consideration

While the Micra AV leadless pacemaker attempts to preserve AV synchrony through accelerometer-based atrial sensing, it has important limitations:

• Not true dual-chamber pacing: The Micra AV uses mechanical sensing of atrial contraction rather than electrical atrial sensing, which has tracking limitations 5
• Risk of pacemaker syndrome: Even with Micra AV, tracking failures can result in symptomatic pacemaker syndrome requiring rescue interventions 5
• Higher baseline comorbidity burden: Patients receiving Micra devices typically have significantly more comorbidities (ESRD 14.9% vs 2.0%, renal dysfunction 47.9% vs 34.2%) 6, suggesting selection bias toward sicker patients where dual-chamber systems may not be feasible

Clinical Decision Algorithm

Choose dual-chamber transvenous pacemaker if:

• Patient has normal sinus node function
• Reasonable life expectancy (>1 year)
• Adequate vascular access
• No contraindications to transvenous leads

Consider Micra VR (single-chamber leadless) only if:

• Permanent atrial fibrillation present
• Vascular access severely limited or impossible
• High infection risk (e.g., dialysis-dependent, recurrent infections)
• Severe comorbidities limiting life expectancy
• Patient explicitly refuses transvenous system after informed discussion

Micra AV may be considered as compromise if:

• Contraindications to transvenous dual-chamber system exist
• Patient has intact sinus node function
• Understanding that AV synchrony may be imperfect and rescue interventions possible

Common Pitfalls to Avoid

1. Don't default to Micra just because it's "newer": The 2024 data shows Micra patients had higher all-cause mortality (adjusted HR 1.53) despite lower complication rates 6, reflecting appropriate patient selection for sicker individuals

2. Don't assume Micra AV equals dual-chamber: The accelerometer-based sensing is not equivalent to true atrial electrical sensing and has documented tracking limitations 5

3. Don't ignore upgrade needs: While Micra had lower overall re-intervention rates, upgrades to CRT were similar between groups (1.6% vs 1.7%), and 1.4% of Micra patients required upgrade to dual-chamber systems 6

4. Don't overlook the 2024 comparative data: The most recent large-scale study of 19,219 matched patients definitively demonstrates dual-chamber superiority for mortality, heart failure, AF, and stroke outcomes in complete AV block with sinus rhythm 4

The evidence strongly supports dual-chamber transvenous pacing as the standard of care for third-degree AV block with intact sinus rhythm, reserving leadless systems for patients with specific contraindications to transvenous approaches.